These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 189219)

  • 1. Inoculation experiment of Marek's disease vaccine contaminated with a reticuloendotheliosis virus.
    Kawamura H; Wakabayashi T; Yamaguchi S; Taniguchi T; Takayanagi N
    Natl Inst Anim Health Q (Tokyo); 1976; 16(4):135-40. PubMed ID: 189219
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isolation of a reticuloendotheliosis virus from chickens inoculated with Marek's disease vaccine.
    Yuasa N; Yoshida I; Taniguchi T
    Natl Inst Anim Health Q (Tokyo); 1976; 16(4):141-51. PubMed ID: 189220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Infection studies on a reticuloendotheliosis virus contaminant of a commercial Marek's disease vaccine.
    Bagust TJ; Grimes TM; Dennett DP
    Aust Vet J; 1979 Apr; 55(4):153-7. PubMed ID: 223539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathological changes in chickens inoculated with reticuloendotheliosis-virus-contaminated Marek's disease vaccine.
    Taniguchi T; Yuasa N; Sato S; Horiuchi T
    Natl Inst Anim Health Q (Tokyo); 1977; 17(4):141-50. PubMed ID: 203872
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relative efficiency of techniques for detecting avian reticuloendotheliosis virus as a vaccine contaminant.
    Nicholas RA; Thornton DH
    Res Vet Sci; 1983 May; 34(3):377-9. PubMed ID: 6308736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaccination against Marek's disease: possible causes of failure of herpesvirus of turkeys (strain FC126) to protect chickens against Marek's disease.
    Okazaki W; Purchase HG; Burmester BR
    Am J Vet Res; 1973 Jun; 34(6):813-7. PubMed ID: 4350544
    [No Abstract]   [Full Text] [Related]  

  • 7. Marek's disease in turkeys: lack of protection by vaccination.
    Elmubarak AK; Sharma JM; Witter RL; Sanger VL
    Am J Vet Res; 1982 Apr; 43(4):740-2. PubMed ID: 6280536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Duration of vaccinal immunity against Marek's disease.
    Witter RL; Offenbecker L
    Avian Dis; 1978; 22(3):396-408. PubMed ID: 211999
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reticuloendotheliosis group virus pathogenic to chicken isolated from material infected with turkey herpesvirus (HVT).
    Koyama H; Suzuki Y; Ohwada Y; Saito Y
    Avian Dis; 1976; 20(2):429-34. PubMed ID: 180962
    [No Abstract]   [Full Text] [Related]  

  • 10. Common occurrence of Gallid herpesvirus-2 with reticuloendotheliosis virus in chickens caused by possible contamination of vaccine stocks.
    Woźniakowski G; Mamczur A; Samorek-Salamonowicz E
    J Appl Microbiol; 2015 Apr; 118(4):803-8. PubMed ID: 25641090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Field trials with a bivalent vaccine (HVT and SB-1) against Marek's disease.
    Calnek BW; Schat KA; Peckham MC; Fabricant J
    Avian Dis; 1983; 27(3):844-9. PubMed ID: 6314982
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of cell-free or cell-associated turkey herpesvirus vaccine against Marek's disease in chickens as influenced by maternal antibody, vaccine dose, and time of exposure to Marek's disease virus.
    Eidson CS; Page RK; Kleven SH
    Avian Dis; 1978; 22(4):583-97. PubMed ID: 219826
    [No Abstract]   [Full Text] [Related]  

  • 13. Prevention of Marek's disease: a review.
    Purchase HG
    Cancer Res; 1976 Feb; 36(2 pt 2):696-700. PubMed ID: 766959
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Marek's disease tumors in chickens vaccinated with turkey herpesvirus vaccine.
    Eidson CS
    Dev Biol Stand; 1982; 52():437-46. PubMed ID: 7166202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of cell associated vaccines against Marek's disease virus grown in a continuous cell line from chickens.
    Geerligs H; Quanz S; Suurland B; Spijkers IE; Rodenberg J; Davelaar FG; Jongsma B; Kumar M
    Vaccine; 2008 Oct; 26(44):5595-600. PubMed ID: 18706949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of maternal antibody on efficacy of embryo vaccination with cell-associated and cell-free Marek's disease vaccine.
    Sharma JM; Graham CK
    Avian Dis; 1982; 26(4):860-70. PubMed ID: 6297450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of a bivalent vaccine against Marek's disease.
    Pruthi AK; Gupta RK; Sadana JR
    Res Vet Sci; 1987 Mar; 42(2):145-9. PubMed ID: 3035660
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Enhanced pathenogicity of chicken anemia agent (CAA) in dual infections with Marek's disease virus (MDV), infectious bursal disease virus (IBDV) or reticuloendotheliosis virus (REV)].
    von Bülow V; Rudolph R; Fuchs B
    Zentralbl Veterinarmed B; 1986 Mar; 33(2):93-116. PubMed ID: 3014789
    [No Abstract]   [Full Text] [Related]  

  • 19. Turkey herpesvirus. VII. The evolution of Marek's disease in chickens vaccinated at one day of age and challenged at different periods of time after vaccination.
    Pătraşcu IV; Calnek BV; Smith M
    Virologie; 1988; 39(1):35-40. PubMed ID: 2837003
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of the efficacy against Marek's disease of cell-free and cell-associated turkey herpesvirus vaccine.
    Eidson CS; Villegas P; Page RK; Kleven SH
    Avian Dis; 1975; 19(3):515-24. PubMed ID: 1164319
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.